Mitoxantrone
- Generic Name
- Mitoxantrone
- Drug Type
- Small Molecule
- Chemical Formula
- C22H28N4O6
- CAS Number
- 65271-80-9
- Unique Ingredient Identifier
- BZ114NVM5P
Overview
An anthracenedione-derived antineoplastic agent.
Background
An anthracenedione-derived antineoplastic agent.
Indication
For the treatment of secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis
Associated Conditions
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia
- Acute Promyelocytic Leukemia
- Hodgkin's Lymphoma
- Metastatic Breast Cancer
- Non-Hodgkin's Lymphoma (NHL)
- Progressive Relapsing Multiple Sclerosis
- Relapsed Leukemia
- Relapsed Lymphomas
- Relapsing Remitting Multiple Sclerosis (RRMS)
- Secondary Progressive Multiple Sclerosis (SPMS)
- Hormone refractory, advanced Prostate cancer
- Relapsed Hepatocellular carcinoma
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath